Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Genta-Foil resorb is a **transparent, absorbable collagen foil** for implantation during surgery to act as a temporary barrier between tissues. It is made from *equine collagen* and is impregnated with the **aminoglycoside antibiotic gentamicin sulphate**[1][4][7][9][10]. The device is designed to prevent tissue adhesions (such as between muscles, tendons, and nerves), provide **local antibiotic prophylaxis**, and facilitate wound healing after trauma or surgical interventions, especially in orthopaedics and hand surgery[3][4][5][6][7][10]. The foil is **biocompatible**, resorbable (no need for removal), naturally cross-linked, and can be easily molded when moistened. The mechanism of action combines mechanical separation to prevent adhesion formation and localized antibiotic action to reduce infection risk[1][4][7][10]. Gentamicin acts bactericidally by inhibiting bacterial protein synthesis via binding to the 30S ribosomal subunit. The product was developed for surgical infection prevention, tissue regeneration, and integration at implantation sites[1][4][7][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Genta-Foil resorb.